Services

Serving the biopharmaceutical needs of Canadians

The Biological Manufacturing Center (BMC) Inc. is licenced by Health Canada for Biomanufacturing since obtaining the Drug Establishment licence in 2022.

The 54, 900 square feet (ft2) single-use, self-contained facility is set up with end-to-end production capabilities comprising:

Cleanrooms designed for biocontainment level 2 (CL2) and with capability to handle from 50L up to 2000L biological material.

Centralised station equipped with multiple single use mixing vessels to provide required media and buffer solutions to each manufacturing suite.

Flexibility and capacity to scale up or down and accommodate multiple product production campaigns simultaneously, based on single-use technology platform.

LEARN MORE ABOUT OUR FACILITY